nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—Drostanolone—Estradiol—osteoporosis	0.353	0.711	CrCrCtD
Finasteride—Testosterone—Estradiol—osteoporosis	0.143	0.289	CrCrCtD
Finasteride—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0395	0.151	CbGbCtD
Finasteride—CYP3A7—Estradiol—osteoporosis	0.0395	0.151	CbGbCtD
Finasteride—CYP3A5—Estradiol—osteoporosis	0.0296	0.113	CbGbCtD
Finasteride—CYP3A4—Estropipate—osteoporosis	0.0278	0.106	CbGbCtD
Finasteride—CYP3A4—Calcitriol—osteoporosis	0.0278	0.106	CbGbCtD
Finasteride—CYP3A4—Ergocalciferol—osteoporosis	0.0222	0.0849	CbGbCtD
Finasteride—CYP3A4—Raloxifene—osteoporosis	0.0185	0.0708	CbGbCtD
Finasteride—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0179	0.0684	CbGbCtD
Finasteride—CYP3A4—Cholecalciferol—osteoporosis	0.0143	0.0547	CbGbCtD
Finasteride—CYP3A4—Conjugated Estrogens—osteoporosis	0.0131	0.0502	CbGbCtD
Finasteride—CYP3A4—Estradiol—osteoporosis	0.0115	0.0441	CbGbCtD
Finasteride—AKR1D1—Synthesis of bile acids and bile salts via 24-hydroxycholesterol—CYP27A1—osteoporosis	0.00798	0.0968	CbGpPWpGaD
Finasteride—AKR1D1—Synthesis of bile acids and bile salts via 27-hydroxycholesterol—CYP27A1—osteoporosis	0.00755	0.0916	CbGpPWpGaD
Finasteride—AKR1D1—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—CYP27A1—osteoporosis	0.00518	0.0629	CbGpPWpGaD
Finasteride—AKR1D1—Synthesis of bile acids and bile salts—CYP27A1—osteoporosis	0.00472	0.0572	CbGpPWpGaD
Finasteride—AKR1D1—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.00375	0.0455	CbGpPWpGaD
Finasteride—SRD5A1—Androgen biosynthesis—POMC—osteoporosis	0.00343	0.0416	CbGpPWpGaD
Finasteride—SRD5A2—Androgen biosynthesis—POMC—osteoporosis	0.00343	0.0416	CbGpPWpGaD
Finasteride—Breast cancer—Zoledronate—osteoporosis	0.00253	0.0163	CcSEcCtD
Finasteride—Breast cancer—Conjugated Estrogens—osteoporosis	0.00244	0.0156	CcSEcCtD
Finasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—CYP19A1—osteoporosis	0.00237	0.0287	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—CYP19A1—osteoporosis	0.00237	0.0287	CbGpPWpGaD
Finasteride—Breast tenderness—Estradiol—osteoporosis	0.00219	0.014	CcSEcCtD
Finasteride—Trauma—Pamidronate—osteoporosis	0.00213	0.0136	CcSEcCtD
Finasteride—Breast enlargement—Estropipate—osteoporosis	0.00208	0.0133	CcSEcCtD
Finasteride—Breast cancer—Estradiol—osteoporosis	0.00195	0.0125	CcSEcCtD
Finasteride—Breast enlargement—Ethinyl Estradiol—osteoporosis	0.00168	0.0108	CcSEcCtD
Finasteride—Neoplasm malignant—Estropipate—osteoporosis	0.00158	0.0101	CcSEcCtD
Finasteride—Tenderness—Estropipate—osteoporosis	0.00154	0.0099	CcSEcCtD
Finasteride—Drostanolone—SHBG—osteoporosis	0.00154	0.376	CrCbGaD
Finasteride—Neoplasm malignant—Raloxifene—osteoporosis	0.00153	0.0098	CcSEcCtD
Finasteride—Tenderness—Raloxifene—osteoporosis	0.0015	0.00959	CcSEcCtD
Finasteride—Neoplasm malignant—Calcitriol—osteoporosis	0.00148	0.0095	CcSEcCtD
Finasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.00142	0.0173	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.00142	0.0173	CbGpPWpGaD
Finasteride—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.0014	0.0169	CbGpPWpGaD
Finasteride—Breast enlargement—Conjugated Estrogens—osteoporosis	0.00137	0.0088	CcSEcCtD
Finasteride—Neoplasm—Estropipate—osteoporosis	0.00122	0.00781	CcSEcCtD
Finasteride—Neoplasm malignant—Pamidronate—osteoporosis	0.00119	0.0076	CcSEcCtD
Finasteride—Drostanolone—CYP19A1—osteoporosis	0.00113	0.276	CrCbGaD
Finasteride—Breast enlargement—Estradiol—osteoporosis	0.0011	0.00704	CcSEcCtD
Finasteride—Neoplasm malignant—Zoledronate—osteoporosis	0.00108	0.00694	CcSEcCtD
Finasteride—Injury—Estropipate—osteoporosis	0.00106	0.00682	CcSEcCtD
Finasteride—Swelling—Ibandronate—osteoporosis	0.00106	0.00682	CcSEcCtD
Finasteride—AKR1D1—Metapathway biotransformation—CYP27A1—osteoporosis	0.00106	0.0128	CbGpPWpGaD
Finasteride—Neoplasm malignant—Conjugated Estrogens—osteoporosis	0.00104	0.00669	CcSEcCtD
Finasteride—Tenderness—Conjugated Estrogens—osteoporosis	0.00102	0.00654	CcSEcCtD
Finasteride—Injury—Ibandronate—osteoporosis	0.00102	0.00654	CcSEcCtD
Finasteride—Libido decreased—Calcitriol—osteoporosis	0.00099	0.00635	CcSEcCtD
Finasteride—Neoplasm—Ethinyl Estradiol—osteoporosis	0.000987	0.00633	CcSEcCtD
Finasteride—Neoplasm—Risedronate—osteoporosis	0.000963	0.00617	CcSEcCtD
Finasteride—Disturbance in sexual arousal—Calcitriol—osteoporosis	0.000911	0.00584	CcSEcCtD
Finasteride—Breast disorder—Estropipate—osteoporosis	0.000884	0.00567	CcSEcCtD
Finasteride—Breast disorder—Raloxifene—osteoporosis	0.000856	0.00549	CcSEcCtD
Finasteride—Libido decreased—Ethinyl Estradiol—osteoporosis	0.000855	0.00548	CcSEcCtD
Finasteride—Breast disorder—Ibandronate—osteoporosis	0.000847	0.00544	CcSEcCtD
Finasteride—Influenza—Estropipate—osteoporosis	0.000845	0.00542	CcSEcCtD
Finasteride—Injury—Risedronate—osteoporosis	0.000841	0.00539	CcSEcCtD
Finasteride—Neoplasm—Zoledronate—osteoporosis	0.000836	0.00536	CcSEcCtD
Finasteride—Neoplasm malignant—Estradiol—osteoporosis	0.000834	0.00535	CcSEcCtD
Finasteride—Swelling—Pamidronate—osteoporosis	0.000833	0.00534	CcSEcCtD
Finasteride—Influenza—Raloxifene—osteoporosis	0.000819	0.00525	CcSEcCtD
Finasteride—Tenderness—Estradiol—osteoporosis	0.000817	0.00524	CcSEcCtD
Finasteride—Influenza—Ibandronate—osteoporosis	0.000811	0.0052	CcSEcCtD
Finasteride—Neoplasm—Conjugated Estrogens—osteoporosis	0.000805	0.00516	CcSEcCtD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000804	0.00976	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000804	0.00976	CbGpPWpGaD
Finasteride—Injury—Pamidronate—osteoporosis	0.000799	0.00513	CcSEcCtD
Finasteride—Hypotension—Calcium Acetate—osteoporosis	0.000791	0.00507	CcSEcCtD
Finasteride—Bronchitis—Raloxifene—osteoporosis	0.000787	0.00505	CcSEcCtD
Finasteride—Disturbance in sexual arousal—Ethinyl Estradiol—osteoporosis	0.000786	0.00504	CcSEcCtD
Finasteride—Bronchitis—Ibandronate—osteoporosis	0.00078	0.005	CcSEcCtD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000762	0.00925	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000762	0.00925	CbGpPWpGaD
Finasteride—Swelling—Zoledronate—osteoporosis	0.000761	0.00488	CcSEcCtD
Finasteride—Swelling—Conjugated Estrogens—osteoporosis	0.000732	0.0047	CcSEcCtD
Finasteride—Pain—Calcium Acetate—osteoporosis	0.000724	0.00464	CcSEcCtD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000717	0.0087	CbGpPWpGaD
Finasteride—Breast disorder—Ethinyl Estradiol—osteoporosis	0.000716	0.00459	CcSEcCtD
Finasteride—Sinusitis—Estropipate—osteoporosis	0.000707	0.00453	CcSEcCtD
Finasteride—Injury—Conjugated Estrogens—osteoporosis	0.000703	0.00451	CcSEcCtD
Finasteride—Breast disorder—Risedronate—osteoporosis	0.000698	0.00448	CcSEcCtD
Finasteride—Sinusitis—Raloxifene—osteoporosis	0.000685	0.00439	CcSEcCtD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00068	0.00825	CbGpPWpGaD
Finasteride—Rhinitis—Estropipate—osteoporosis	0.000678	0.00435	CcSEcCtD
Finasteride—Pharyngitis—Estropipate—osteoporosis	0.000671	0.00431	CcSEcCtD
Finasteride—Influenza—Risedronate—osteoporosis	0.000668	0.00428	CcSEcCtD
Finasteride—Oedema peripheral—Estropipate—osteoporosis	0.000666	0.00427	CcSEcCtD
Finasteride—Bronchitis—Ethinyl Estradiol—osteoporosis	0.000659	0.00423	CcSEcCtD
Finasteride—Rhinitis—Raloxifene—osteoporosis	0.000657	0.00421	CcSEcCtD
Finasteride—Oedema peripheral—Alendronate—osteoporosis	0.000656	0.00421	CcSEcCtD
Finasteride—Pharyngitis—Raloxifene—osteoporosis	0.00065	0.00417	CcSEcCtD
Finasteride—Oedema peripheral—Raloxifene—osteoporosis	0.000646	0.00414	CcSEcCtD
Finasteride—Neoplasm—Estradiol—osteoporosis	0.000644	0.00413	CcSEcCtD
Finasteride—Pharyngitis—Ibandronate—osteoporosis	0.000644	0.00413	CcSEcCtD
Finasteride—Bronchitis—Risedronate—osteoporosis	0.000642	0.00412	CcSEcCtD
Finasteride—Pain—Ergocalciferol—osteoporosis	0.000639	0.0041	CcSEcCtD
Finasteride—Oedema peripheral—Ibandronate—osteoporosis	0.000639	0.0041	CcSEcCtD
Finasteride—Gynaecomastia—Estradiol—osteoporosis	0.000637	0.00409	CcSEcCtD
Finasteride—Influenza—Pamidronate—osteoporosis	0.000635	0.00407	CcSEcCtD
Finasteride—Hypersensitivity—Calcium Acetate—osteoporosis	0.000624	0.004	CcSEcCtD
Finasteride—Angioedema—Etidronic acid—osteoporosis	0.000622	0.00399	CcSEcCtD
Finasteride—Immune system disorder—Estropipate—osteoporosis	0.000611	0.00392	CcSEcCtD
Finasteride—Asthenia—Calcium Acetate—osteoporosis	0.000607	0.00389	CcSEcCtD
Finasteride—Pruritus—Calcium Acetate—osteoporosis	0.000599	0.00384	CcSEcCtD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000593	0.0072	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000593	0.0072	CbGpPWpGaD
Finasteride—Mental disorder—Estropipate—osteoporosis	0.000593	0.0038	CcSEcCtD
Finasteride—Swelling—Estradiol—osteoporosis	0.000586	0.00376	CcSEcCtD
Finasteride—Immune system disorder—Ibandronate—osteoporosis	0.000586	0.00376	CcSEcCtD
Finasteride—Breast disorder—Conjugated Estrogens—osteoporosis	0.000584	0.00375	CcSEcCtD
Finasteride—Influenza—Zoledronate—osteoporosis	0.00058	0.00372	CcSEcCtD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000578	0.00701	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000578	0.00701	CbGpPWpGaD
Finasteride—Sinusitis—Ethinyl Estradiol—osteoporosis	0.000573	0.00368	CcSEcCtD
Finasteride—Mental disorder—Ibandronate—osteoporosis	0.000568	0.00365	CcSEcCtD
Finasteride—Injury—Estradiol—osteoporosis	0.000563	0.00361	CcSEcCtD
Finasteride—Dizziness—Calcium Acetate—osteoporosis	0.00056	0.00359	CcSEcCtD
Finasteride—Sinusitis—Risedronate—osteoporosis	0.000559	0.00358	CcSEcCtD
Finasteride—Influenza—Conjugated Estrogens—osteoporosis	0.000559	0.00358	CcSEcCtD
Finasteride—Libido decreased—Estradiol—osteoporosis	0.000558	0.00358	CcSEcCtD
Finasteride—AKR1D1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000556	0.00674	CbGpPWpGaD
Finasteride—Infection—Etidronic acid—osteoporosis	0.000552	0.00354	CcSEcCtD
Finasteride—Rhinitis—Ethinyl Estradiol—osteoporosis	0.00055	0.00353	CcSEcCtD
Finasteride—Pharyngitis—Ethinyl Estradiol—osteoporosis	0.000544	0.00349	CcSEcCtD
Finasteride—Angioedema—Estropipate—osteoporosis	0.000538	0.00345	CcSEcCtD
Finasteride—Bronchitis—Conjugated Estrogens—osteoporosis	0.000537	0.00344	CcSEcCtD
Finasteride—Asthenia—Ergocalciferol—osteoporosis	0.000536	0.00344	CcSEcCtD
Finasteride—Rhinitis—Risedronate—osteoporosis	0.000536	0.00344	CcSEcCtD
Finasteride—Sinusitis—Pamidronate—osteoporosis	0.000531	0.00341	CcSEcCtD
Finasteride—Pharyngitis—Risedronate—osteoporosis	0.000531	0.0034	CcSEcCtD
Finasteride—Angioedema—Alendronate—osteoporosis	0.00053	0.0034	CcSEcCtD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000529	0.00641	CbGpPWpGaD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000527	0.00639	CbGpPWpGaD
Finasteride—Oedema peripheral—Risedronate—osteoporosis	0.000527	0.00338	CcSEcCtD
Finasteride—CYP3A7—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00052	0.00631	CbGpPWpGaD
Finasteride—Angioedema—Ibandronate—osteoporosis	0.000516	0.00331	CcSEcCtD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000515	0.00625	CbGpPWpGaD
Finasteride—Disturbance in sexual arousal—Estradiol—osteoporosis	0.000513	0.00329	CcSEcCtD
Finasteride—Rhinitis—Pamidronate—osteoporosis	0.00051	0.00327	CcSEcCtD
Finasteride—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.000495	0.00318	CcSEcCtD
Finasteride—Immune system disorder—Risedronate—osteoporosis	0.000483	0.0031	CcSEcCtD
Finasteride—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00048	0.00308	CcSEcCtD
Finasteride—Infection—Estropipate—osteoporosis	0.000478	0.00306	CcSEcCtD
Finasteride—Infection—Alendronate—osteoporosis	0.00047	0.00302	CcSEcCtD
Finasteride—Mental disorder—Risedronate—osteoporosis	0.000468	0.003	CcSEcCtD
Finasteride—Breast disorder—Estradiol—osteoporosis	0.000467	0.003	CcSEcCtD
Finasteride—Sinusitis—Conjugated Estrogens—osteoporosis	0.000467	0.003	CcSEcCtD
Finasteride—Infection—Raloxifene—osteoporosis	0.000463	0.00297	CcSEcCtD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000462	0.00561	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000462	0.00561	CbGpPWpGaD
Finasteride—Immune system disorder—Pamidronate—osteoporosis	0.000459	0.00294	CcSEcCtD
Finasteride—Infection—Ibandronate—osteoporosis	0.000458	0.00294	CcSEcCtD
Finasteride—Oedema peripheral—Zoledronate—osteoporosis	0.000457	0.00293	CcSEcCtD
Finasteride—Rhinitis—Conjugated Estrogens—osteoporosis	0.000448	0.00287	CcSEcCtD
Finasteride—Influenza—Estradiol—osteoporosis	0.000447	0.00287	CcSEcCtD
Finasteride—Pharyngitis—Conjugated Estrogens—osteoporosis	0.000444	0.00285	CcSEcCtD
Finasteride—Urticaria—Etidronic acid—osteoporosis	0.000441	0.00283	CcSEcCtD
Finasteride—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.00044	0.00282	CcSEcCtD
Finasteride—Angioedema—Ethinyl Estradiol—osteoporosis	0.000436	0.0028	CcSEcCtD
Finasteride—Progesterone—SHBG—osteoporosis	0.000432	0.105	CrCbGaD
Finasteride—Bronchitis—Estradiol—osteoporosis	0.00043	0.00276	CcSEcCtD
Finasteride—Somnolence—Estropipate—osteoporosis	0.000427	0.00274	CcSEcCtD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000427	0.00518	CbGpPWpGaD
Finasteride—Angioedema—Risedronate—osteoporosis	0.000425	0.00273	CcSEcCtD
Finasteride—Immune system disorder—Zoledronate—osteoporosis	0.000419	0.00269	CcSEcCtD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000412	0.005	CbGpPWpGaD
Finasteride—Pain—Estropipate—osteoporosis	0.000411	0.00264	CcSEcCtD
Finasteride—Hypersensitivity—Etidronic acid—osteoporosis	0.000409	0.00263	CcSEcCtD
Finasteride—Testosterone—SHBG—osteoporosis	0.000408	0.0994	CrCbGaD
Finasteride—Mental disorder—Zoledronate—osteoporosis	0.000407	0.00261	CcSEcCtD
Finasteride—Pain—Alendronate—osteoporosis	0.000405	0.0026	CcSEcCtD
Finasteride—Angioedema—Pamidronate—osteoporosis	0.000404	0.00259	CcSEcCtD
Finasteride—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000404	0.00259	CcSEcCtD
Finasteride—Somnolence—Calcitriol—osteoporosis	0.000401	0.00257	CcSEcCtD
Finasteride—Pain—Raloxifene—osteoporosis	0.000398	0.00255	CcSEcCtD
Finasteride—Pain—Ibandronate—osteoporosis	0.000394	0.00253	CcSEcCtD
Finasteride—Pruritus—Etidronic acid—osteoporosis	0.000393	0.00252	CcSEcCtD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000393	0.00477	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000393	0.00477	CbGpPWpGaD
Finasteride—Mental disorder—Conjugated Estrogens—osteoporosis	0.000392	0.00251	CcSEcCtD
Finasteride—Infection—Ethinyl Estradiol—osteoporosis	0.000387	0.00248	CcSEcCtD
Finasteride—Pain—Calcitriol—osteoporosis	0.000386	0.00247	CcSEcCtD
Finasteride—Urticaria—Estropipate—osteoporosis	0.000382	0.00245	CcSEcCtD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000381	0.00462	CbGpPWpGaD
Finasteride—Infection—Risedronate—osteoporosis	0.000377	0.00242	CcSEcCtD
Finasteride—Urticaria—Alendronate—osteoporosis	0.000376	0.00241	CcSEcCtD
Finasteride—CYP3A5—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000376	0.00456	CbGpPWpGaD
Finasteride—Sinusitis—Estradiol—osteoporosis	0.000374	0.0024	CcSEcCtD
Finasteride—Angioedema—Zoledronate—osteoporosis	0.000369	0.00237	CcSEcCtD
Finasteride—Urticaria—Ibandronate—osteoporosis	0.000366	0.00235	CcSEcCtD
Finasteride—Infection—Pamidronate—osteoporosis	0.000359	0.0023	CcSEcCtD
Finasteride—Rhinitis—Estradiol—osteoporosis	0.000359	0.0023	CcSEcCtD
Finasteride—Urticaria—Calcitriol—osteoporosis	0.000358	0.0023	CcSEcCtD
Finasteride—SRD5A1—Metabolism—PKM—osteoporosis	0.000358	0.00435	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PKM—osteoporosis	0.000358	0.00435	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—FDPS—osteoporosis	0.000358	0.00435	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—FDPS—osteoporosis	0.000358	0.00435	CbGpPWpGaD
Finasteride—Angioedema—Conjugated Estrogens—osteoporosis	0.000356	0.00228	CcSEcCtD
Finasteride—Pharyngitis—Estradiol—osteoporosis	0.000355	0.00228	CcSEcCtD
Finasteride—Hypersensitivity—Estropipate—osteoporosis	0.000354	0.00227	CcSEcCtD
Finasteride—Oedema peripheral—Estradiol—osteoporosis	0.000352	0.00226	CcSEcCtD
Finasteride—Rash—Etidronic acid—osteoporosis	0.00035	0.00225	CcSEcCtD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.00035	0.00425	CbGpPWpGaD
Finasteride—Dermatitis—Etidronic acid—osteoporosis	0.00035	0.00224	CcSEcCtD
Finasteride—Hypersensitivity—Alendronate—osteoporosis	0.000349	0.00224	CcSEcCtD
Finasteride—Headache—Etidronic acid—osteoporosis	0.000348	0.00223	CcSEcCtD
Finasteride—Asthenia—Estropipate—osteoporosis	0.000345	0.00221	CcSEcCtD
Finasteride—Pruritus—Estropipate—osteoporosis	0.00034	0.00218	CcSEcCtD
Finasteride—Asthenia—Alendronate—osteoporosis	0.00034	0.00218	CcSEcCtD
Finasteride—Hypersensitivity—Ibandronate—osteoporosis	0.00034	0.00218	CcSEcCtD
Finasteride—SRD5A2—Metabolism—GPD2—osteoporosis	0.00034	0.00412	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PGLS—osteoporosis	0.00034	0.00412	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GPD2—osteoporosis	0.00034	0.00412	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PGLS—osteoporosis	0.00034	0.00412	CbGpPWpGaD
Finasteride—Dyspnoea—Risedronate—osteoporosis	0.000339	0.00217	CcSEcCtD
Finasteride—Hypotension—Pamidronate—osteoporosis	0.000337	0.00216	CcSEcCtD
Finasteride—Pruritus—Alendronate—osteoporosis	0.000335	0.00215	CcSEcCtD
Finasteride—Hypersensitivity—Calcitriol—osteoporosis	0.000332	0.00213	CcSEcCtD
Finasteride—Asthenia—Ibandronate—osteoporosis	0.000331	0.00212	CcSEcCtD
Finasteride—Infection—Zoledronate—osteoporosis	0.000328	0.0021	CcSEcCtD
Finasteride—Pruritus—Ibandronate—osteoporosis	0.000326	0.00209	CcSEcCtD
Finasteride—Pain—Risedronate—osteoporosis	0.000325	0.00208	CcSEcCtD
Finasteride—Asthenia—Calcitriol—osteoporosis	0.000324	0.00208	CcSEcCtD
Finasteride—Immune system disorder—Estradiol—osteoporosis	0.000323	0.00207	CcSEcCtD
Finasteride—Dyspnoea—Pamidronate—osteoporosis	0.000322	0.00206	CcSEcCtD
Finasteride—Somnolence—Pamidronate—osteoporosis	0.000321	0.00206	CcSEcCtD
Finasteride—AKR1D1—Metabolism—PKM—osteoporosis	0.000319	0.00387	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—FDPS—osteoporosis	0.000319	0.00387	CbGpPWpGaD
Finasteride—Pruritus—Calcitriol—osteoporosis	0.000319	0.00205	CcSEcCtD
Finasteride—Dizziness—Estropipate—osteoporosis	0.000318	0.00204	CcSEcCtD
Finasteride—Infection—Conjugated Estrogens—osteoporosis	0.000316	0.00202	CcSEcCtD
Finasteride—Mental disorder—Estradiol—osteoporosis	0.000313	0.00201	CcSEcCtD
Finasteride—Dizziness—Alendronate—osteoporosis	0.000313	0.00201	CcSEcCtD
Finasteride—SRD5A1—Metabolism—PNP—osteoporosis	0.000311	0.00377	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PNP—osteoporosis	0.000311	0.00377	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ATIC—osteoporosis	0.000311	0.00377	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ATIC—osteoporosis	0.000311	0.00377	CbGpPWpGaD
Finasteride—Urticaria—Ethinyl Estradiol—osteoporosis	0.00031	0.00198	CcSEcCtD
Finasteride—Pain—Pamidronate—osteoporosis	0.000309	0.00198	CcSEcCtD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000309	0.00375	CbGpPWpGaD
Finasteride—Hypotension—Zoledronate—osteoporosis	0.000308	0.00198	CcSEcCtD
Finasteride—Dizziness—Raloxifene—osteoporosis	0.000308	0.00197	CcSEcCtD
Finasteride—Dizziness—Ibandronate—osteoporosis	0.000305	0.00195	CcSEcCtD
Finasteride—Rash—Estropipate—osteoporosis	0.000303	0.00194	CcSEcCtD
Finasteride—Dermatitis—Estropipate—osteoporosis	0.000303	0.00194	CcSEcCtD
Finasteride—AKR1D1—Metabolism—PGLS—osteoporosis	0.000303	0.00367	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GPD2—osteoporosis	0.000303	0.00367	CbGpPWpGaD
Finasteride—Urticaria—Risedronate—osteoporosis	0.000302	0.00194	CcSEcCtD
Finasteride—Headache—Estropipate—osteoporosis	0.000301	0.00193	CcSEcCtD
Finasteride—Testosterone—CYP19A1—osteoporosis	0.0003	0.073	CrCbGaD
Finasteride—Rash—Alendronate—osteoporosis	0.000299	0.00191	CcSEcCtD
Finasteride—Dermatitis—Alendronate—osteoporosis	0.000298	0.00191	CcSEcCtD
Finasteride—Hypotension—Conjugated Estrogens—osteoporosis	0.000297	0.0019	CcSEcCtD
Finasteride—Headache—Alendronate—osteoporosis	0.000297	0.0019	CcSEcCtD
Finasteride—Dyspnoea—Zoledronate—osteoporosis	0.000294	0.00189	CcSEcCtD
Finasteride—Rash—Raloxifene—osteoporosis	0.000294	0.00188	CcSEcCtD
Finasteride—Dermatitis—Raloxifene—osteoporosis	0.000293	0.00188	CcSEcCtD
Finasteride—Somnolence—Zoledronate—osteoporosis	0.000293	0.00188	CcSEcCtD
Finasteride—Progesterone—ESR1—osteoporosis	0.000292	0.071	CrCbGaD
Finasteride—Headache—Raloxifene—osteoporosis	0.000292	0.00187	CcSEcCtD
Finasteride—Rash—Ibandronate—osteoporosis	0.000291	0.00186	CcSEcCtD
Finasteride—Dermatitis—Ibandronate—osteoporosis	0.00029	0.00186	CcSEcCtD
Finasteride—Headache—Ibandronate—osteoporosis	0.000289	0.00185	CcSEcCtD
Finasteride—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000287	0.00184	CcSEcCtD
Finasteride—Angioedema—Estradiol—osteoporosis	0.000285	0.00183	CcSEcCtD
Finasteride—Rash—Calcitriol—osteoporosis	0.000284	0.00182	CcSEcCtD
Finasteride—Dermatitis—Calcitriol—osteoporosis	0.000284	0.00182	CcSEcCtD
Finasteride—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000283	0.00182	CcSEcCtD
Finasteride—Headache—Calcitriol—osteoporosis	0.000283	0.00181	CcSEcCtD
Finasteride—Somnolence—Conjugated Estrogens—osteoporosis	0.000282	0.00181	CcSEcCtD
Finasteride—Pain—Zoledronate—osteoporosis	0.000282	0.00181	CcSEcCtD
Finasteride—Hypersensitivity—Risedronate—osteoporosis	0.00028	0.00179	CcSEcCtD
Finasteride—Asthenia—Ethinyl Estradiol—osteoporosis	0.00028	0.00179	CcSEcCtD
Finasteride—AKR1D1—Metabolism—PNP—osteoporosis	0.000277	0.00336	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ATIC—osteoporosis	0.000277	0.00336	CbGpPWpGaD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000277	0.00336	CbGpPWpGaD
Finasteride—Pruritus—Ethinyl Estradiol—osteoporosis	0.000276	0.00177	CcSEcCtD
Finasteride—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000273	0.00331	CbGpPWpGaD
Finasteride—Asthenia—Risedronate—osteoporosis	0.000273	0.00175	CcSEcCtD
Finasteride—Pain—Conjugated Estrogens—osteoporosis	0.000272	0.00174	CcSEcCtD
Finasteride—Pruritus—Risedronate—osteoporosis	0.000269	0.00172	CcSEcCtD
Finasteride—Hypersensitivity—Pamidronate—osteoporosis	0.000266	0.00171	CcSEcCtD
Finasteride—SRD5A2—Metabolism—CA2—osteoporosis	0.000264	0.0032	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CA2—osteoporosis	0.000264	0.0032	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—OXCT1—osteoporosis	0.000264	0.0032	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—OXCT1—osteoporosis	0.000264	0.0032	CbGpPWpGaD
Finasteride—Urticaria—Zoledronate—osteoporosis	0.000262	0.00168	CcSEcCtD
Finasteride—Asthenia—Pamidronate—osteoporosis	0.000259	0.00166	CcSEcCtD
Finasteride—Dizziness—Ethinyl Estradiol—osteoporosis	0.000258	0.00165	CcSEcCtD
Finasteride—SRD5A2—Metabolism—MGLL—osteoporosis	0.000257	0.00312	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—MGLL—osteoporosis	0.000257	0.00312	CbGpPWpGaD
Finasteride—Pruritus—Pamidronate—osteoporosis	0.000255	0.00164	CcSEcCtD
Finasteride—Infection—Estradiol—osteoporosis	0.000253	0.00162	CcSEcCtD
Finasteride—Urticaria—Conjugated Estrogens—osteoporosis	0.000252	0.00162	CcSEcCtD
Finasteride—Dizziness—Risedronate—osteoporosis	0.000251	0.00161	CcSEcCtD
Finasteride—Rash—Ethinyl Estradiol—osteoporosis	0.000246	0.00158	CcSEcCtD
Finasteride—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000245	0.00157	CcSEcCtD
Finasteride—Headache—Ethinyl Estradiol—osteoporosis	0.000244	0.00157	CcSEcCtD
Finasteride—Hypersensitivity—Zoledronate—osteoporosis	0.000243	0.00156	CcSEcCtD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000243	0.00295	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000243	0.00295	CbGpPWpGaD
Finasteride—Rash—Risedronate—osteoporosis	0.00024	0.00154	CcSEcCtD
Finasteride—Dermatitis—Risedronate—osteoporosis	0.000239	0.00153	CcSEcCtD
Finasteride—Dizziness—Pamidronate—osteoporosis	0.000239	0.00153	CcSEcCtD
Finasteride—Headache—Risedronate—osteoporosis	0.000238	0.00153	CcSEcCtD
Finasteride—Asthenia—Zoledronate—osteoporosis	0.000237	0.00152	CcSEcCtD
Finasteride—AKR1D1—Metabolism—CA2—osteoporosis	0.000235	0.00286	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—OXCT1—osteoporosis	0.000235	0.00286	CbGpPWpGaD
Finasteride—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000234	0.0015	CcSEcCtD
Finasteride—Pruritus—Zoledronate—osteoporosis	0.000233	0.0015	CcSEcCtD
Finasteride—AKR1D1—Metabolism—MGLL—osteoporosis	0.000229	0.00278	CbGpPWpGaD
Finasteride—Asthenia—Conjugated Estrogens—osteoporosis	0.000228	0.00146	CcSEcCtD
Finasteride—Rash—Pamidronate—osteoporosis	0.000228	0.00146	CcSEcCtD
Finasteride—Dermatitis—Pamidronate—osteoporosis	0.000227	0.00146	CcSEcCtD
Finasteride—CYP3A7—Biological oxidations—CYP27A1—osteoporosis	0.000227	0.00275	CbGpPWpGaD
Finasteride—Dyspnoea—Estradiol—osteoporosis	0.000227	0.00145	CcSEcCtD
Finasteride—Headache—Pamidronate—osteoporosis	0.000226	0.00145	CcSEcCtD
Finasteride—Somnolence—Estradiol—osteoporosis	0.000226	0.00145	CcSEcCtD
Finasteride—Pruritus—Conjugated Estrogens—osteoporosis	0.000225	0.00144	CcSEcCtD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000224	0.00272	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP27A1—osteoporosis	0.000224	0.00272	CbGpPWpGaD
Finasteride—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000223	0.00271	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—IDH2—osteoporosis	0.000219	0.00266	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—IDH2—osteoporosis	0.000219	0.00266	CbGpPWpGaD
Finasteride—Dizziness—Zoledronate—osteoporosis	0.000218	0.0014	CcSEcCtD
Finasteride—Pain—Estradiol—osteoporosis	0.000217	0.00139	CcSEcCtD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000216	0.00262	CbGpPWpGaD
Finasteride—Dizziness—Conjugated Estrogens—osteoporosis	0.00021	0.00135	CcSEcCtD
Finasteride—Rash—Zoledronate—osteoporosis	0.000208	0.00133	CcSEcCtD
Finasteride—Dermatitis—Zoledronate—osteoporosis	0.000208	0.00133	CcSEcCtD
Finasteride—Headache—Zoledronate—osteoporosis	0.000207	0.00133	CcSEcCtD
Finasteride—SRD5A2—Metabolism—CYP27A1—osteoporosis	0.000206	0.0025	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP27A1—osteoporosis	0.000206	0.0025	CbGpPWpGaD
Finasteride—Urticaria—Estradiol—osteoporosis	0.000202	0.0013	CcSEcCtD
Finasteride—Rash—Conjugated Estrogens—osteoporosis	0.0002	0.00128	CcSEcCtD
Finasteride—SRD5A2—Metabolism—ACP5—osteoporosis	0.0002	0.00243	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ACP5—osteoporosis	0.0002	0.00243	CbGpPWpGaD
Finasteride—Dermatitis—Conjugated Estrogens—osteoporosis	0.0002	0.00128	CcSEcCtD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.0002	0.00243	CbGpPWpGaD
Finasteride—Headache—Conjugated Estrogens—osteoporosis	0.000199	0.00128	CcSEcCtD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000198	0.0024	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000198	0.0024	CbGpPWpGaD
Finasteride—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000197	0.0024	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—IDH2—osteoporosis	0.000195	0.00237	CbGpPWpGaD
Finasteride—Hypersensitivity—Estradiol—osteoporosis	0.000187	0.0012	CcSEcCtD
Finasteride—SRD5A1—Metabolism—TPI1—osteoporosis	0.000186	0.00226	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—TPI1—osteoporosis	0.000186	0.00226	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP27A1—osteoporosis	0.000183	0.00223	CbGpPWpGaD
Finasteride—Asthenia—Estradiol—osteoporosis	0.000182	0.00117	CcSEcCtD
Finasteride—Pruritus—Estradiol—osteoporosis	0.00018	0.00115	CcSEcCtD
Finasteride—AKR1D1—Metabolism—ACP5—osteoporosis	0.000178	0.00216	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000177	0.00215	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000176	0.00214	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—P4HB—osteoporosis	0.000175	0.00212	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—P4HB—osteoporosis	0.000175	0.00212	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000175	0.00212	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GAPDH—osteoporosis	0.000172	0.00208	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GAPDH—osteoporosis	0.000172	0.00208	CbGpPWpGaD
Finasteride—Dizziness—Estradiol—osteoporosis	0.000168	0.00108	CcSEcCtD
Finasteride—SRD5A1—Metabolism—RAP1A—osteoporosis	0.000167	0.00203	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—RAP1A—osteoporosis	0.000167	0.00203	CbGpPWpGaD
Finasteride—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000167	0.00202	CbGpPWpGaD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000166	0.00202	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—TPI1—osteoporosis	0.000166	0.00201	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP27A1—osteoporosis	0.000164	0.00199	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000162	0.00197	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP27A1—osteoporosis	0.000162	0.00196	CbGpPWpGaD
Finasteride—Rash—Estradiol—osteoporosis	0.00016	0.00103	CcSEcCtD
Finasteride—Dermatitis—Estradiol—osteoporosis	0.00016	0.00103	CcSEcCtD
Finasteride—Headache—Estradiol—osteoporosis	0.000159	0.00102	CcSEcCtD
Finasteride—AKR1D1—Metabolism—P4HB—osteoporosis	0.000156	0.00189	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GAPDH—osteoporosis	0.000153	0.00186	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—RAP1A—osteoporosis	0.000149	0.00181	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000146	0.00177	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000146	0.00177	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000144	0.00174	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ENO1—osteoporosis	0.000135	0.00164	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ENO1—osteoporosis	0.000135	0.00164	CbGpPWpGaD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000135	0.00164	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PSMA5—osteoporosis	0.000133	0.00162	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PSMA2—osteoporosis	0.000133	0.00162	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PSMA5—osteoporosis	0.000133	0.00162	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PSMA2—osteoporosis	0.000133	0.00162	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.00013	0.00158	CbGpPWpGaD
Finasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000128	0.00155	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ENO1—osteoporosis	0.00012	0.00146	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.00012	0.00146	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP19A1—osteoporosis	0.000119	0.00145	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PSMA2—osteoporosis	0.000119	0.00144	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PSMA5—osteoporosis	0.000119	0.00144	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP19A1—osteoporosis	0.000118	0.00143	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000115	0.0014	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP19A1—osteoporosis	0.000108	0.00131	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP19A1—osteoporosis	0.000108	0.00131	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.75e-05	0.00118	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP19A1—osteoporosis	9.63e-05	0.00117	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	9.3e-05	0.00113	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	9.18e-05	0.00111	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ADCY5—osteoporosis	8.83e-05	0.00107	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ADCY5—osteoporosis	8.83e-05	0.00107	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GPX1—osteoporosis	8.8e-05	0.00107	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GPX1—osteoporosis	8.8e-05	0.00107	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	8.61e-05	0.00105	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	8.5e-05	0.00103	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—MTHFR—osteoporosis	8.12e-05	0.000986	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—MTHFR—osteoporosis	8.12e-05	0.000986	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ADCY5—osteoporosis	7.87e-05	0.000955	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GPX1—osteoporosis	7.84e-05	0.000952	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	7.62e-05	0.000925	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.54e-05	0.000915	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	7.52e-05	0.000913	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—MTHFR—osteoporosis	7.24e-05	0.000878	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—POMC—osteoporosis	7.16e-05	0.000869	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—FDPS—osteoporosis	6.76e-05	0.00082	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PKM—osteoporosis	6.76e-05	0.00082	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—POMC—osteoporosis	6.49e-05	0.000788	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—POMC—osteoporosis	6.49e-05	0.000788	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GPD2—osteoporosis	6.4e-05	0.000777	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PGLS—osteoporosis	6.4e-05	0.000777	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PNP—osteoporosis	5.86e-05	0.000711	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ATIC—osteoporosis	5.86e-05	0.000711	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—POMC—osteoporosis	5.79e-05	0.000703	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.59e-05	0.000678	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—POMC—osteoporosis	5.18e-05	0.000628	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—OXCT1—osteoporosis	4.98e-05	0.000604	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CA2—osteoporosis	4.98e-05	0.000604	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PKM—osteoporosis	4.88e-05	0.000593	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—FDPS—osteoporosis	4.88e-05	0.000593	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MGLL—osteoporosis	4.85e-05	0.000589	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PGLS—osteoporosis	4.63e-05	0.000562	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GPD2—osteoporosis	4.63e-05	0.000562	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.53e-05	0.00055	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PNP—osteoporosis	4.23e-05	0.000514	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ATIC—osteoporosis	4.23e-05	0.000514	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—IDH2—osteoporosis	4.13e-05	0.000501	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.01e-05	0.000486	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.95e-05	0.000479	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP27A1—osteoporosis	3.88e-05	0.000471	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ACP5—osteoporosis	3.77e-05	0.000458	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—OXCT1—osteoporosis	3.6e-05	0.000437	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CA2—osteoporosis	3.6e-05	0.000437	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—TPI1—osteoporosis	3.51e-05	0.000426	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MGLL—osteoporosis	3.51e-05	0.000426	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—P4HB—osteoporosis	3.3e-05	0.0004	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GAPDH—osteoporosis	3.24e-05	0.000393	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—RAP1A—osteoporosis	3.15e-05	0.000383	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—IDH2—osteoporosis	2.98e-05	0.000362	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.8e-05	0.00034	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ACP5—osteoporosis	2.73e-05	0.000331	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ENO1—osteoporosis	2.55e-05	0.000309	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—TPI1—osteoporosis	2.54e-05	0.000308	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PSMA2—osteoporosis	2.51e-05	0.000305	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PSMA5—osteoporosis	2.51e-05	0.000305	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—POMC—osteoporosis	2.41e-05	0.000292	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—P4HB—osteoporosis	2.38e-05	0.000289	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GAPDH—osteoporosis	2.34e-05	0.000284	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—RAP1A—osteoporosis	2.28e-05	0.000277	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PKM—osteoporosis	2.27e-05	0.000276	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—FDPS—osteoporosis	2.27e-05	0.000276	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GPD2—osteoporosis	2.15e-05	0.000261	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PGLS—osteoporosis	2.15e-05	0.000261	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP19A1—osteoporosis	2.04e-05	0.000247	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ATIC—osteoporosis	1.97e-05	0.000239	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PNP—osteoporosis	1.97e-05	0.000239	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ENO1—osteoporosis	1.84e-05	0.000224	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PSMA5—osteoporosis	1.82e-05	0.00022	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PSMA2—osteoporosis	1.82e-05	0.00022	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—OXCT1—osteoporosis	1.67e-05	0.000203	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CA2—osteoporosis	1.67e-05	0.000203	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ADCY5—osteoporosis	1.67e-05	0.000202	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GPX1—osteoporosis	1.66e-05	0.000201	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MGLL—osteoporosis	1.63e-05	0.000198	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MTHFR—osteoporosis	1.53e-05	0.000186	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.47e-05	0.000179	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—IDH2—osteoporosis	1.39e-05	0.000168	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.3e-05	0.000158	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ACP5—osteoporosis	1.27e-05	0.000154	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—POMC—osteoporosis	1.22e-05	0.000149	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ADCY5—osteoporosis	1.2e-05	0.000146	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GPX1—osteoporosis	1.2e-05	0.000146	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—TPI1—osteoporosis	1.18e-05	0.000143	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—P4HB—osteoporosis	1.11e-05	0.000135	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MTHFR—osteoporosis	1.11e-05	0.000134	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GAPDH—osteoporosis	1.09e-05	0.000132	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—RAP1A—osteoporosis	1.06e-05	0.000129	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—POMC—osteoporosis	8.85e-06	0.000107	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ENO1—osteoporosis	8.57e-06	0.000104	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PSMA2—osteoporosis	8.44e-06	0.000102	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PSMA5—osteoporosis	8.44e-06	0.000102	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.85e-06	8.31e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ADCY5—osteoporosis	5.6e-06	6.79e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GPX1—osteoporosis	5.58e-06	6.77e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MTHFR—osteoporosis	5.15e-06	6.25e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—POMC—osteoporosis	4.12e-06	5e-05	CbGpPWpGaD
